Literature DB >> 29925010

The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.

Christopher J Ricketts, Aguirre A De Cubas, Huihui Fan, Christof C Smith, Martin Lang, Ed Reznik, Reanne Bowlby, Ewan A Gibb, Rehan Akbani, Rameen Beroukhim, Donald P Bottaro, Toni K Choueiri, Richard A Gibbs, Andrew K Godwin, Scott Haake, A Ari Hakimi, Elizabeth P Henske, James J Hsieh, Thai H Ho, Rupa S Kanchi, Bhavani Krishnan, David J Kwiatkowski, Wembin Lui, Maria J Merino, Gordon B Mills, Jerome Myers, Michael L Nickerson, Victor E Reuter, Laura S Schmidt, C Simon Shelley, Hui Shen, Brian Shuch, Sabina Signoretti, Ramaprasad Srinivasan, Pheroze Tamboli, George Thomas, Benjamin G Vincent, Cathy D Vocke, David A Wheeler, Lixing Yang, William Y Kim, A Gordon Robertson, Paul T Spellman, W Kimryn Rathmell, W Marston Linehan.   

Abstract

Entities:  

Year:  2018        PMID: 29925010     DOI: 10.1016/j.celrep.2018.06.032

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


× No keyword cloud information.
  77 in total

1.  Cabozantinib in advanced non-clear-cell renal cell carcinoma: is it the way clearer now?

Authors:  Giulia Di Pierro; Enrico Mini; Giandomenico Roviello
Journal:  Ann Transl Med       Date:  2019-09

2.  Another one in the chamber: cabozantinib for patients with metastatic non clear cell renal cell carcinoma.

Authors:  Vincenzo Di Nunno; Francesco Massari; Veronica Mollica; Alessia Cimadamore; Matteo Santoni; Liang Cheng; Antonio Lopez-Beltran; Marina Scarpelli; Rodolfo Montironi
Journal:  Ann Transl Med       Date:  2019-07

3.  Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study.

Authors:  Nieves Martínez Chanzá; Wanling Xie; Mehmet Asim Bilen; Hannah Dzimitrowicz; Jarred Burkart; Daniel M Geynisman; Archana Balakrishnan; I Alex Bowman; Rohit Jain; Walter Stadler; Yousef Zakharia; Vivek Narayan; Benoit Beuselinck; Rana R McKay; Abhishek Tripathi; Russell Pachynski; Andrew W Hahn; JoAnn Hsu; Sumit A Shah; Elaine T Lam; Tracy L Rose; Anthony E Mega; Nicholas Vogelzang; Michael R Harrison; Amir Mortazavi; Elizabeth R Plimack; Ulka Vaishampayan; Hans Hammers; Saby George; Naomi Haas; Neeraj Agarwal; Sumanta K Pal; Sandy Srinivas; Benedito A Carneiro; Daniel Y C Heng; Dominick Bosse; Toni K Choueiri; Lauren C Harshman
Journal:  Lancet Oncol       Date:  2019-02-28       Impact factor: 41.316

Review 4.  A Meta-Analysis Evaluating Clinical Outcomes of Patients with Renal Cell Carcinoma Harboring Chromosome 9P Loss.

Authors:  Vincenzo Di Nunno; Veronica Mollica; Matteo Brunelli; Lidia Gatto; Riccardo Schiavina; Michelangelo Fiorentino; Matteo Santoni; Rodolfo Montironi; Anna Caliò; Albino Eccher; Michele Milella; Guido Martignoni; Eugenio Brunocilla; Francesco Massari
Journal:  Mol Diagn Ther       Date:  2019-10       Impact factor: 4.074

5.  JAK2/PD-L1/PD-L2 (9p24.1) amplifications in renal cell carcinomas with sarcomatoid transformation: implications for clinical management.

Authors:  Sounak Gupta; John C Cheville; Achim A Jungbluth; Yanming Zhang; Lei Zhang; Ying-Bei Chen; Satish K Tickoo; Samson W Fine; Anuradha Gopalan; Hikmat A Al-Ahmadie; Sahussapont J Sirintrapun; Kyle A Blum; Christine M Lohse; A Ari Hakimi; R Houston Thompson; Bradley C Leibovich; Michael F Berger; Maria E Arcila; Dara S Ross; Marc Ladanyi; Cristina R Antonescu; Victor E Reuter
Journal:  Mod Pathol       Date:  2019-04-17       Impact factor: 7.842

6.  [Ginsenoside 20(S)-Rg3 upregulates tumor suppressor VHL gene expression by suppressing DNMT3A-mediated promoter methylation in ovarian cancer cells].

Authors:  Lijie Wang; Xi Han; Xia Zheng; Yuanyuan Zhou; Huilian Hou; Wei Chen; Xu Li; Le Zhao
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-01-30

Review 7.  Tumor Microenvironment Dynamics in Clear-Cell Renal Cell Carcinoma.

Authors:  Lynda Vuong; Ritesh R Kotecha; Martin H Voss; A Ari Hakimi
Journal:  Cancer Discov       Date:  2019-09-16       Impact factor: 39.397

8.  Putative Drivers of Aggressiveness in TCEB1-mutant Renal Cell Carcinoma: An Emerging Entity with Variable Clinical Course.

Authors:  Renzo G DiNatale; Alexander N Gorelick; Vladimir Makarov; Kyle A Blum; Andrew W Silagy; Benjamin Freeman; Diego Chowell; Julian Marcon; Roy Mano; Alex Sanchez; Kyrollis Attalla; Stanley Weng; Martin Voss; Robert J Motzer; Paul Russo; Jonathan A Coleman; Victor E Reuter; Ying-Bei Chen; Timothy A Chan; Ed Reznik; Satish K Tickoo; A Ari Hakimi
Journal:  Eur Urol Focus       Date:  2019-12-06

9.  Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade.

Authors:  Robert J Motzer; Romain Banchereau; Habib Hamidi; Thomas Powles; David McDermott; Michael B Atkins; Bernard Escudier; Li-Fen Liu; Ning Leng; Alexander R Abbas; Jinzhen Fan; Hartmut Koeppen; Jennifer Lin; Susheela Carroll; Kenji Hashimoto; Sanjeev Mariathasan; Marjorie Green; Darren Tayama; Priti S Hegde; Christina Schiff; Mahrukh A Huseni; Brian Rini
Journal:  Cancer Cell       Date:  2020-11-05       Impact factor: 31.743

Review 10.  Metabolic Pathways in Kidney Cancer: Current Therapies and Future Directions.

Authors:  W Kimryn Rathmell; Jeffrey C Rathmell; W Marston Linehan
Journal:  J Clin Oncol       Date:  2018-10-29       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.